Kenneth Bate Madrigal Pharmaceuticals, Inc. (MDGL) insider trading activity

MDGL Quotes by TradingView

Kenneth Bate is Director of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 2,627 shares of MDGL, which is worth approximately $1.39 Million. The most recent transaction as insider was on Nov 05, 2025, when has been sold 16,575 shares (Common Stock) at a price of $485.61 per share, resulting in proceeds of $8,048,985. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.63K
0% 3M change
37.4% 12M change
Total Value Held $1.39 Million

KENNETH BATE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 05 2025
SELL
Open market or private sale
$8,048,985 $485.61 p/Share
16,575 Reduced 86.32%
2,627 Common Stock
Nov 05 2025
BUY
Exercise of conversion of derivative security
$3,277,872 $197.76 p/Share
16,575 Added 46.33%
19,202 Common Stock
Aug 15 2025
SELL
Open market or private sale
$3,658,900 $365.89 p/Share
10,000 Reduced 79.2%
2,627 Common Stock
Aug 15 2025
BUY
Exercise of conversion of derivative security
$164,600 $16.46 p/Share
10,000 Added 44.19%
12,627 Common Stock
Jun 20 2025
BUY
Grant, award, or other acquisition
-
715 Added 21.39%
2,627 Common Stock
Feb 27 2025
SELL
Open market or private sale
$7,118,400 $355.92 p/Share
20,000 Reduced 91.27%
1,912 Common Stock
Feb 27 2025
BUY
Exercise of conversion of derivative security
$1,237,200 $61.86 p/Share
20,000 Added 47.72%
21,912 Common Stock
Jun 25 2024
BUY
Grant, award, or other acquisition
-
714 Added 27.19%
1,912 Common Stock
Apr 02 2024
SELL
Open market or private sale
$2,759,945 $246.16 p/Share
11,212 Reduced 90.35%
1,198 Common Stock
Apr 02 2024
BUY
Exercise of conversion of derivative security
$1,178,156 $105.08 p/Share
11,212 Added 47.46%
12,410 Common Stock
Apr 01 2024
SELL
Open market or private sale
$5,551,382 $260.91 p/Share
21,277 Reduced 94.67%
1,198 Common Stock
Apr 01 2024
BUY
Exercise of conversion of derivative security
$1,524,709 $71.66 p/Share
21,277 Added 48.63%
22,475 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
1,198 Added 50.0%
1,198 Common Stock

Also insider at

ATXS
Astria Therapeutics, Inc. Healthcare
Director
AVEO
AVEO PHARMACEUTICALS, INC. Healthcare
Director
EPZM
Epizyme, Inc. Healthcare
Director
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
Director
KB

Kenneth Bate

Director
Cambridge, MA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MDGL